Cisplatin Cytotoxicity of Auditory Cells Requires Secretions of Proinflammatory Cytokines via Activation of ERK and NF-κB-Reference-Cited by-同舟云学术

Cisplatin Cytotoxicity of Auditory Cells Requires Secretions of Proinflammatory Cytokines via Activation of ERK and NF-κB

Published:2007-05-22 Issue:3 Volume:8 Page:338-355
ISSN:1525-3961
Container-title:Journal of the Association for Research in Otolaryngology
language:en
Short-container-title:JARO

Author:

So Hongseob,Kim HyungJin,Lee Jeong-Han,Park Channy,Kim Yunha,Kim Eunsook,Kim Jin-Kyung,Yun Ki-Jung,Lee Kang-Min,Lee Haa-Yung,Moon Sung-Kyun,Lim David J.,Park Raekil

Publisher

Springer Science and Business Media LLC

Subject

Sensory Systems,Otorhinolaryngology

Link

http://link.springer.com/content/pdf/10.1007/s10162-007-0084-9.pdf

Reference62 articles.

1. Abraham E. Nuclear factor-kappaB and its role in sepsis-associated organ failure. J. Infect. Dis. 187(Suppl 2):S364–S369, 2003.

2. Alam SA, Ikeda K, Oshima T, Suzuki M, Kawase T, Kikuchi T, Takasaka T. Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hear Res. 141:28–38, 2000.

3. Arany I, Megyesi JK, Kaneto H, Price PM, Safirstein RL. Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. Am. J. Physiol. Renal. Physiol. 287:F543–F549, 2004.

4. Baldwin AS, Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649–683, 1996.

5. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066–1071, 1997.

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing biocompatibility of the brain-machine interface: A review;Bioactive Materials;2024-12

2. Gene therapy advancements for the treatment of acquired and hereditary hearing loss;Frontiers in Audiology and Otology;2024-07-17

3. Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss;Pharmaceuticals;2024-06-05

4. FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing Loss;2024-05-21

5. Oseltamivir (Tamiflu), a Commonly Prescribed Antiviral Drug, Mitigates Hearing Loss in Mice;2024-05-08